Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree. It is finally coming together. Your timeline seems resonable and I like that they are putting dates on progress.
Still need to reread that last pr and I encourage everyone else to do so as well. In the short term that partnership will be our best bet for a much higher pps. And long term it will help the pet division succeed. Another point worth making is the last pr mentioned an equity position, not a simple partnership. That would. E huge, not just for the pet division, also for the human side.
Great news, win-win for all! Can’t wait.
If the testing will be done by the end of February, maybe we'll see the pharmaceutical partnership finalized and announced in March? Followed by sales in June. Looks like we are almost at the finish line
Great news. Glad to hear they are moving forward with production and very close to bringing the product to market. I am really looking forward to a PR on test results. I need to go back and reread the last major pr. No doubt the test results will be very important to future partners in the pet cgm.
News! Memorandum of Understanding signed their CGM and launch date is now June!
https://www.alrt.com/news/2021/12/07/alrt-infinovo-mou
ALR Technologies and Infinovo Sign Memorandum of Understanding to Manufacture World’s First CGM for Diabetic Pets
(December 7, 2021 -- Singapore) ALR Technologies (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, is pleased to announce the signing of a Memorandum of Understanding (“MOU”) with Infinovo Medical Co. Ltd for a global supply agreement of their P3 Continuous Glucose Monitor (CGM) for use by ALRT in the animal health sector.
Under the terms of the MOU, ALR Technologies and Infinovo will collaborate to integrate Infinovo’s P3 CGM with ALRT’s proprietary GluCurve platform. The Company expects to begin testing the GluCurve Pet CGM in veterinary clinics in late December 2021 or early January 2022. The testing is scheduled to complete by the end of February 2022.
“We are excited to take this significant step forward with Infinovo,” said Sidney Chan, Chairman and CEO of ALRT. “By combining the talents, strengths, and resources of both companies, we anticipate bringing the GluCurve Pet CGM to market much faster than previously expected. We are planning to commence commercial delivery as early as June, 2022. Working with Infinovo will provide ALRT the cutting edge hardware needed for our GluCurve Pet CGM in order to provide veterinarians the solution to diabetes management they are desperately seeking.”
Joe Stern, Head of Animal Health at ALR Technologies continued, “My team is thrilled to work with Infinovo and to begin commercial testing of the GluCurve Pet CGM in the coming weeks. Various interested parties, such as our potential pharmaceutical partners, veterinary consultants, and others in animal health are all eager to review the results and we are confident they will be impressed.”
The OEM agreement between ALRT and Infinovo is subject to further negotiations and the execution of a definitive document acceptable to both parties.
About Infinovo Medical Co. Ltd
Founded in 2016, Infinovo is an innovative medical technology company, focusing on developing an accurate and affordable CGM for patients which will be available for both Type 1 and Type 2 Diabetics. https://en.infinovo.com
About ALR Technologies
ALR Technologies is a data management company that developed the ALRT Diabetes Solution, a comprehensive approach to diabetes care that includes: an FDA-cleared and HIPAA compliant diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices; a patent pending Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. ALRT also offers an algorithm to provide prescribers support for timely non-insulin medication advancements. The overall goal is to optimize diabetes drug therapies to drive improved patient outcomes. The program tracks performance of all clinical activities to ensure best practices are followed. The ALRT Diabetes Solution gives healthcare providers a platform for remote diabetes care, helping to minimize patient exposure to potential infections in clinical settings. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.
In addition, the animal health division has identified an unmet need in diabetes care and has developed a solution to assist veterinarians in determining the effectiveness of insulin and helping to identify the appropriate dose and frequency of administration for companion animals. Thus, delivering the same optimization of diabetic drug therapies to pets as to humans.
ALR Technologies SG Pte. Ltd. is a wholly owned subsidiary of ALR Technologies Inc. On June 1, 2021, ALR Technologies Inc. announced its intention to migrate to Singapore. More information about ALR Technologies Inc. can be found at https://www.alrt.com. Regarding ALR Technologies SG Pte. Ltd. Information can be found at https://sg.alrt.com.
Contact
Ken Robulak (US)
Phone: +1 (727) 736-3838
Anthony Ngai (Singapore)
Phone: +65 3129 2924
Email: ir@alrt.com
This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties, and assumptions. When used, the words "estimate", "expect", "anticipate", "believe", “will” and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance, or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the Company's quarterly filings with the Securities Exchange Commission.
0452. Only sellers here. Merry Christmas.
0458. Merry Christmas! Dollarland any day now!
I wasn't so lucky. I was in Europe when it fell to pieces and didn't stay on top of it. Lost thousands. GLTUA
Lol, I was on that bandwagon also, but managed to escape with a few hundred dollar profit months before the collapse. Maybe alrt needs some tv commercials, that got me to invest in abw
That's what they were saying with Airborne Wireless. Buy more! A sure bet! We're all gonna be rich!!! LOL
.0465 Merry Christmas. No seriously, Merry Christmas, buy more.
Cool post! This should greatly help all pets with diabetes, and benefit shareholders as well.
0465. Merry Christmas!
Just waiting for that revenue deal "coming any day now" before this ticker sees trips and us longs become bag holders. GLTUA!
Really appreciate all tour posts and enthusiasm! Yes this stock will make us rich .. all in due time.. unfortunately this board is toxic due to a few .. holding 5mil plus shares strong. See you on the forbes list in a few years
Animal health is going to make us rich IMO, there is a ton of information on the internet but I actually think the presentation on alrt.com does a great job of summarizing it based on my DD. But instead of going over my thoughts on any of that, let me tell you what my personal veterinarian had to say about it because I think that paints a better picture since its from his personal experience as a vet.
I’ve known my veterinarian for many years so It’s easy to talk to him about a pet CGM, plus he is very interested in the subject because he said he sees a lot of diabetic pets and even gets referrals from other clinics. He basically told me all the same things that are already in the ALRT investor presentation, currently the way to monitor diabetic pets is to have the owner drop them off at the vet clinic at opening for a blood glucose curve which consists of drawing blood with a needle every two hours to collect 6 samples over 12 hours. He said Insulin is given to most pets twice a day 12 hours apart so the idea is that it gives them the blood sugar levels during that time.
He said that is one of the many problems with doing a blood glucose curve, there are half a dozen or more insulins that can be used and every pet reacts differently to every insulin. 12 hours isn’t even close to enough time to see the full effects of the insulins, and besides that, the readings they get are usually off because the pet gets stressed out which changes the readings. They don’t like being crated in the clinic with strangers and other animals around, but mainly they hate getting their blood drawn because of the prick of the needle and the pressure of the blood draw itself. So most of the time they have to hold the pets down with special gloves and a thick towel to draw blood without getting scratched or bitten.
He said quite candidly that the pets and pet owners hate the whole experience, and so does he and his staff. But he also said that its expensive for the pet owners, he has to charge $200-$250 and that barely leaves any profit after covering the costs of housing the pet all day along with pulling him and his staff away every two hours when they could be seeing other patients.
He said that he attended a continuing education conference a few years ago on diabetes and they said back then that using a CGM is the future. He said some veterinarians do currently use the Freestyle Libre CGM which is for humans, but that comes with a ton of problems. He said the maker (Abbott) wont support the use of their product on animals, and the only way to get one is to write a prescription to the pet owner and have them go pick it up at a pharmacy. He said he personally doesn’t use them because after the pet owner spends $60-$100 to get one, he then has to charge for his time to put it on and then again to take it off and try and go over the results. It makes it very expensive for the pet owner but it also is difficult because all the blood sugar readings it takes are on the pet owners phone so its hard for him to analyze. He also said it has to be scanned every 8 hours or you lose the readings because its not a true CGM and pet owners will forget to scan it and it throws off all the graphs and readings.
Long story short, he said the ALRT pet CGM sounded amazing and would be a game changer. He agreed with ALRTs presentation that all veterinarians would switch to using a pet CGM (ALRT said 97% from their market research) over doing the blood glucose curves in their clinic. But he also said he is quite interested in their platform because if it analyzed the readings for him that would save a ton of time and be really helpful.
Hopefully that wasn’t too long, but we talk about the ALRT pet CGM every time I bring my dog in so I’ve been able to ask him a lot of questions from doing my own research online to better understand the animal health space. I don’t post on ihub much anymore because nobody here seems to do or share any of their own due diligence, even when news comes out nobody has anything to say and there is no excitement around it so I don’t bother anymore. But I will continue to accumulate as much as I can for as long as I can before it takes off. I’ve said it a million times that even if it takes 5 years, if you see 10x returns who in their right mind wouldn’t wait?
"The stock market is a device for transferring money from the impatient to the patient." – Warren Buffett
Drip drip drip. Where is this company going?
I've been watching silver. Yes, probably time to buy.
This is an opportunity, not a disaster. Buy silver bullion, too. It was down below $24/oz yesterday. Keep an eye on silver.
0505 Merry Christmas!
We have a little volume today. Bail out of this ticker volume!
They sold something so it's a start lol
man, it's getting pretty steamy in here...
hi last one,
hope all's good with you and yours.
any chance you could do some digging and share any dd you
glean?
i, and perhaps others, would be appreciative.
tia, glty
glta
LOL. $2,100 in 2021 with a gross margin of $757 and a net operating loss of over $1,000,000 this year. Over the last 3-3/4 years, they've lost $6.8 million.
Not ready to declare victory just yet.
Anyone read the 10q, I saw there was some revenue in there
Mckvee do us all a favor and please try to sell your few hundred dollars worth of shares. Listening to you whine weekly is exhausting. Move on to your next penny stock and let the rest of us be in peace as we continue to support the LONG TERM vision of this company, not just a few cents up or down. Sell and be done with it.
The only volume trading in this ticker is the selling volume - and even that isn't much. Been with ALRT since 2017, and averaged down to my present position under 04. Others have been with them much longer.
Should have dumped this wet dream when we hit 07, assuming I could get rid of my shares without pushing the price down. I've gone from confident to hopeful - at best. Most often these pennies go the other direction.
Still looking for that miracle - that Chan will get a revenue deal sooner than later. But that's all it is... hoping for a miracle. The interest in this stock has all but withered away. Even Mr. Pumper doesn't have much to say about "Dollarland Any Day Now" lately. LOL. GLTU
Sucks to say I'm giving in here.
The stock was looking strong for awhile, running high volume, nice points from 0.05 to 0.06.
Shame to see the management not capitalize on this; they would likely be in a different spot if they decided otherwise.
I'm also out.
LOL. Dollarland any day now. Sure.
We just need to hold strong, and in time she'll be in dollarland.
I'm holding strong, with the odd reup here n there.
Looks like another year will go by with ALRT in the zzzzzzzzzzz mode. But it's "DOLLARLAND" any day now. So we've been told, right? LOL. GLTUA.
Last I heard was that the clinical trials were postponed because of covid.
I'm sure someone else here has more up-to-date info on the Singapore endeavor.
Then we have the consulting firm, SmartPharma, that ALRT contracted to evaluate the diabetes diagnosis, glucose monitoring and insulin treatment markets for cats and dogs. Supposedly, their conclusions was that there would be strong market demand for ALRT's GluCurve(TM)Pet CGM system for pets.
Bottom line is that there is no real NEWS, at least not one that implies a revenue deal. There is no "dollar-land any day now", I don't care what the proponents have been saying for the last 4 years. Therefore, the stock flails around in that 05 to 06 area. I'm still holding, for now.
If you're interested, read this:
A Strong Sell - ALRT
Did we not have some sort of deal with them.How did the trial go? Never heard anything.
Which numbers are those?
Nice to see some new ALRT enthusiasts here. After 4+ years of hearing "It's dollar-land any day now" from the same old pumpers and share price not going anywhere, there's new blood to carry us through these months of share price not going anywhere! LOL. GLTUA!
$ALRT holding out strong, grabbed some at the .53 mark so let's wait for the ice to crumble
Been in this ticker long? I'll tell you what happens. Hovers in the 05 to 06 range. Same goes for tomorrow, next week, next month, and probably next year unless Mr. Chan closes a revenue deal someday. That's what happens.
Yeah.. at least that long for myself too.
Wake me up also, when there is real news. Like a revenue deal. Until then, we'll continue to bounce between 05 and 06 for the foreseeable future. Let's just pray Chan doesn't go to massive dilution or we'll have another Airborne Wireless on our hands. Lost plenty on that POS company and stock.
hi :)
scroll through the old i hub postings... others have been here longer... me; 4 years? i'm in a stupor, wake me up if something happens... glty, glta
Really solid close on Friday, hyped to see what comes monday opening!
Anyone care to share thoughts/plays?
I wonder why we've never heard back from Singapore?
Only been here for a few days but i’m very much so enjoying what im seeing with the recent volume movement, and the amount of news coming out in the last week.
Big ups for ALRT, expecting big things here.
I think that this here stocky is a true speculator.What has it been,like 5 years since FDA approval?I think that either this stock is going to be wildly successful or it's going to be a miserable failure.I think we get our our answer over the next several months.This guy Chan has basically put his whole life into this one and the last mile is the hardest.Just hard to believe that if this product is so good,then why is it taking so long?I'm playing a strong hunch here which is why I bought 23k more today.GLTA.
Since we've been in talks with animal healthcare companies since at least August,I wouldn't be surprised if we got an agreement in place at anytime now.If it's gunna happen,the we have to be very close.The research would indicate that strongly.
Followers
|
148
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
13418
|
Created
|
10/05/09
|
Type
|
Free
|
Moderators |
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |